Mitochondrial Intermediate Peptidase (MIPEP) (C-Term) Peptide
Quick Overview for Mitochondrial Intermediate Peptidase (MIPEP) (C-Term) Peptide (ABIN5671684)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- LRFSHLVGYG ARYYSYLMSR AVASMVWKEC FLQDPFNRAA GERYRREMLA
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- MIPEP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MIPEP (Mitochondrial Intermediate Peptidase (MIPEP))
-
Background
-
The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia.
Alias Symbols: MIP, HMIP
Protein Size: 713 -
Gene ID
- 4285
-
NCBI Accession
- NM_005932, NP_005923
-
UniProt
- Q99797
Target
-